6 Results for "

glycoprotein IIb/IIIa peptide

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "glycoprotein IIb/IIIa peptide" in MCE Product Catalog:

Cat. No.: HY-P1507
CAS No.: 89105-94-2
Target:  

Integrin

Research Areas:  

Cardiovascular Disease

Fibrinogen Binding Inhibitor Peptide is a dodecapeptide (HHLGGAKQAGDV, H12), which is a fibrinogen γ-chain carboxy-terminal sequence (γ400-411). Fibrinogen Binding Inhibitor Peptide is a specific binding site of the ligand for activated glycoprotein (GP) IIb/IIIa.
loading...
    loading...
Cat. No.: HY-10308
CAS No.: 149503-79-7
Target:  

Integrin

Research Areas:  

Metabolic Disease

Lefradafiban is an orally active glycoprotein IIb/IIIa receptor antagonist. Lefradafiban can be metabolized to its active form, Fradafiban, a non-peptide GP IIb/IIIa receptor antagonist .
loading...
    loading...
Cat. No.: HY-U00235
CAS No.: 180144-61-0
Target:  

Integrin

Research Areas:  

Inflammation/Immunology

SR121566A is a novel non-peptide Glycoprotein IIb/IIIa (GP IIb-IIIa) antagonist, which can inhibit ADP-, arachidonic acid- and collagen-induced human platelet aggregation with IC50s of 46±7.5, 56±6 and 42±3 nM, respectively.
loading...
    loading...
Cat. No.: HY-167686
CAS No.: 3187-52-8
Synonyms: Homopisatin
Variabilin (Homopisatin) is a potent RGD-containing antagonist of glycoprotein IIb-IIIa and platelet aggregation inhibitor from the hard tick Dermacentor variabilis. Variabilin potently inhibits platelet aggregation induced by the platelet agonists ADP, collagen, and thrombin receptor peptide SFLLRNP. Variabilin also blocks platelet adhesion to immobilized Fg. In addition, Variabilin inhibits binding of purified human GPIIb-IIIa to immobilized Fg .
loading...
    loading...
Cat. No.: HY-125373
CAS No.: 183745-58-6
Target:  

Integrin

Research Areas:  

Cardiovascular Disease

L-767685, the ethyl ester prodrug of L-767679 (HY-116925), is a non-peptide glycoprotein IIb/IIIa receptor (GPIIb-IIIa receptor) antagonist. L-767679 has a potent anti-platelet aggregation effect. L-767685 can be used for research on antithrombosis .
loading...
    loading...
Cat. No.: HY-107080
CAS No.: 169512-56-5
Target:  

Integrin

Research Areas:  

Cardiovascular Disease

RPR-109891 is an orally active glycoprotein IIb/IIIa peptide antagonist. RPR-109891 can decrease platelet count and reduce platelet survival time. RPR-109891 can be used for the research of cardiovascular disease, such as myocardial infarction .
loading...
    loading...